Pavel Dunaev

404 total citations
32 papers, 293 citations indexed

About

Pavel Dunaev is a scholar working on Gastroenterology, Oncology and Molecular Biology. According to data from OpenAlex, Pavel Dunaev has authored 32 papers receiving a total of 293 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Gastroenterology, 10 papers in Oncology and 8 papers in Molecular Biology. Recurrent topics in Pavel Dunaev's work include Gastrointestinal Tumor Research and Treatment (11 papers), Cancer therapeutics and mechanisms (5 papers) and Sarcoma Diagnosis and Treatment (4 papers). Pavel Dunaev is often cited by papers focused on Gastrointestinal Tumor Research and Treatment (11 papers), Cancer therapeutics and mechanisms (5 papers) and Sarcoma Diagnosis and Treatment (4 papers). Pavel Dunaev collaborates with scholars based in Russia, United States and Türkiye. Pavel Dunaev's co-authors include Sergei Boichuk, Aigul Galembikova, Ramil Khusnutdinov, Pavel Kopnin, И Г Мустафин, Elena Shagimardanova, Svetlana F. Khaiboullina, Oleg Gusev, Н. М. Игидов and Bulat R. Ramazanov and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Molecular Sciences and Molecules.

In The Last Decade

Pavel Dunaev

29 papers receiving 289 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pavel Dunaev Russia 11 122 78 77 77 66 32 293
Aigul Galembikova Russia 11 142 1.2× 85 1.1× 96 1.2× 83 1.1× 74 1.1× 41 338
Anna Kohlmann United States 7 161 1.3× 40 0.5× 59 0.8× 77 1.0× 76 1.2× 10 300
Chengfeng Wang China 12 102 0.8× 109 1.4× 37 0.5× 20 0.3× 69 1.0× 25 309
Calvo Medina United States 6 239 2.0× 164 2.1× 24 0.3× 23 0.3× 33 0.5× 7 339
R. Faissner Germany 10 115 0.9× 232 3.0× 31 0.4× 6 0.1× 30 0.5× 16 365
Canping Ruan China 11 151 1.2× 123 1.6× 23 0.3× 4 0.1× 59 0.9× 18 327
Astrid Drenckhan Germany 10 228 1.9× 130 1.7× 36 0.5× 3 0.0× 28 0.4× 14 362
J Boxall United Kingdom 6 109 0.9× 88 1.1× 60 0.8× 8 0.1× 67 1.0× 7 274
Katherine T. Ostapoff United States 10 146 1.2× 197 2.5× 26 0.3× 4 0.1× 55 0.8× 18 361
Bi-Yun Wang China 5 96 0.8× 73 0.9× 6 0.1× 10 0.1× 67 1.0× 6 253

Countries citing papers authored by Pavel Dunaev

Since Specialization
Citations

This map shows the geographic impact of Pavel Dunaev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pavel Dunaev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pavel Dunaev more than expected).

Fields of papers citing papers by Pavel Dunaev

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pavel Dunaev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pavel Dunaev. The network helps show where Pavel Dunaev may publish in the future.

Co-authorship network of co-authors of Pavel Dunaev

This figure shows the co-authorship network connecting the top 25 collaborators of Pavel Dunaev. A scholar is included among the top collaborators of Pavel Dunaev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pavel Dunaev. Pavel Dunaev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Dunaev, Pavel, Aigul Galembikova, Gülçin Tezcan, et al.. (2024). Leaf Extract from European Olive (Olea europaea L.) Post-Transcriptionally Suppresses the Epithelial-Mesenchymal Transition and Sensitizes Gastric Cancer Cells to Chemotherapy. Biochemistry (Moscow). 89(1). 97–115. 2 indexed citations
4.
Dugina, Vera B., Н. В. Хромова, Svetlana Vinokurova, et al.. (2024). Imbalance between Actin Isoforms Contributes to Tumour Progression in Taxol-Resistant Triple-Negative Breast Cancer Cells. International Journal of Molecular Sciences. 25(8). 4530–4530. 3 indexed citations
5.
Boichuk, Sergei, Pavel Dunaev, Aigul Galembikova, et al.. (2023). Unraveling the Mechanisms of Sensitivity to Anti-FGF Therapies in Imatinib-Resistant Gastrointestinal Stromal Tumors (GIST) Lacking Secondary KIT Mutations. Cancers. 15(22). 5354–5354. 4 indexed citations
6.
Galembikova, Aigul, et al.. (2023). Mechanisms of cytotoxic activity of pyrrole-carboxamides against multidrug-resistant tumor cell sublines. SHILAP Revista de lepidopterología. 10(3). 59–71. 2 indexed citations
7.
Boichuk, Sergei, et al.. (2023). Establishment and Characterization of Multi-Drug Resistant p53-Negative Osteosarcoma SaOS-2 Subline. Diagnostics. 13(16). 2646–2646. 3 indexed citations
8.
9.
Dimiev, Ayrat M., Sergei Boichuk, Pavel Dunaev, et al.. (2020). Dispersion of Single-Walled Carbon Nanotubes in Biocompatible Environments. Nanotechnologies in Russia. 15(7-8). 437–444. 4 indexed citations
10.
Boichuk, Sergei, Aigul Galembikova, Pavel Dunaev, et al.. (2020). Inhibition of FGF2-Mediated Signaling in GIST—Promising Approach for Overcoming Resistance to Imatinib. Cancers. 12(6). 1674–1674. 13 indexed citations
11.
Boichuk, Sergei, et al.. (2019). Ethyl-2-amino-pyrrole-3-carboxylates are active against imatinib-resistant gastrointestinal stromal tumors in vitro and in vivo. Anti-Cancer Drugs. 30(5). 475–484. 6 indexed citations
12.
Galembikova, Aigul, et al.. (2018). Effect of pivaloyl-substituted pyrrole containing heterocyclic compounds on DNA repair pathways in Ewing sarcoma cells. Kazan medical journal. 99(2). 245–248. 1 indexed citations
13.
14.
Игидов, Н. М., et al.. (2018). Synthesis and Biological Activity of 2-amino-1-aryl-5-(3,3-dimethyl-2-oxobutylidene)-4-oxo-N-(thiazol-5-yl)-4,5-dihydro-1h-pyrrole-3-carboxamides. Pharmaceutical Chemistry Journal. 52(3). 198–204. 6 indexed citations
15.
Khusnutdinov, Ramil, et al.. (2017). PIVALOYL-SUBSTITUTED 2-PYRROLONES INDUCE DEATH OF GASTROINTESTINAL STROMAL TUMORS RESISTANT TO IMATINIB AND CHEMOTHERAPY DRUGS. Voprosy Onkologii. 63(1). 135–140. 1 indexed citations
16.
Boichuk, Sergei, et al.. (2017). Establishment and characterization of a triple negative basal-like breast cancer cell line with multi-drug resistance. Oncology Letters. 14(4). 5039–5045. 45 indexed citations
17.
Boichuk, Sergei, Aigul Galembikova, Pavel Dunaev, et al.. (2017). A Novel Receptor Tyrosine Kinase Switch Promotes Gastrointestinal Stromal Tumor Drug Resistance. Molecules. 22(12). 2152–2152. 38 indexed citations
18.
19.
20.
Анохин, В. А., Bulat R. Ramazanov, Pavel Dunaev, et al.. (2014). Activity index of lymphocyte apoptosis in children with neonatal sepsis. Genes and Cells. 9(3). 267–271. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Aigul Galembikova Breakdown of academic impact, for papers by Anna Kohlmann Breakdown of academic impact, for papers by Chengfeng Wang Breakdown of academic impact, for papers by Calvo Medina Breakdown of academic impact, for papers by R. Faissner Breakdown of academic impact, for papers by Canping Ruan Breakdown of academic impact, for papers by Astrid Drenckhan Breakdown of academic impact, for papers by J Boxall Breakdown of academic impact, for papers by Katherine T. Ostapoff Breakdown of academic impact, for papers by Bi-Yun Wang
Rankless by CCL
2026